Clinical development
Evidence behind TRULANCE and our pipeline
Our trials emphasize adult patient safety, meaningful GI outcomes, and transparent reporting.
Trial overview
Key study pillars
Adult populations
Trials focused on adults diagnosed with CIC or IBS-C to align with approved indications.
Efficacy & safety
Endpoints include bowel function improvement, symptom relief, and monitoring of adverse reactions such as diarrhea.
Regulatory rigor
Protocols designed to meet FDA expectations and maintain data integrity across phases.
Transparency
Data access and publications
Summary data and peer-reviewed publications are available for healthcare professionals to review outcomes and safety signals.